Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors.

about

Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors.

Item

http://www.wikidata.org/entity/Q42012376

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@en

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@nl

type

Item

label

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@en

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@nl

prefLabel

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@en

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@nl

P1476

Saudi oncology society and Sau ...... r testicular germ cell tumors.

@en

P2093

Abdullah Alghamdi

http://www.w3.org/2001/XMLSchema#string

Abdullah Alsharm

http://www.w3.org/2001/XMLSchema#string

Ahmad Saadeddin

http://www.w3.org/2001/XMLSchema#string

Ashraf Abusamra

http://www.w3.org/2001/XMLSchema#string

Esam Murshid

http://www.w3.org/2001/XMLSchema#string

Imran Ahmad

http://www.w3.org/2001/XMLSchema#string

Khalid Alghamdi

http://www.w3.org/2001/XMLSchema#string

Mohammed Alotaibi

http://www.w3.org/2001/XMLSchema#string

Mubarak Almansour

http://www.w3.org/2001/XMLSchema#string

Sultan Alkhateeb

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).

Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study.

Clinical stage I testis cancer: long-term outcome of patients on surveillance.

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.

Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.

P304

290-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-7796.140978

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shouki Bazarbashi

D M Rabah

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25371603

http://www.w3.org/2001/XMLSchema#string

P932

4216532

http://www.w3.org/2001/XMLSchema#string